Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update

In the tireless search for innovative and more efficient cancer therapies, sonosensitive Magnetic Resonance Imaging (MRI) agents play an important role. Basically, these systems consist of nano/microvesicles composed by a biocompatible membrane, responsive to ultrasound-induced thermal or mechanical...

Full description

Bibliographic Details
Main Authors: Francesca Garello, Enzo Terreno
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Chemistry
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fchem.2018.00157/full
id doaj-11eb9e8234f64dd088eb7fd151e39790
record_format Article
spelling doaj-11eb9e8234f64dd088eb7fd151e397902020-11-24T21:49:59ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462018-05-01610.3389/fchem.2018.00157360873Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent UpdateFrancesca GarelloEnzo TerrenoIn the tireless search for innovative and more efficient cancer therapies, sonosensitive Magnetic Resonance Imaging (MRI) agents play an important role. Basically, these systems consist of nano/microvesicles composed by a biocompatible membrane, responsive to ultrasound-induced thermal or mechanical effects, and an aqueous core, filled up with a MRI detectable probe and a therapeutic agent. They offer the possibility to trigger and monitor in real time drug release in a spatio-temporal domain, with the expectation to predict the therapeutic outcome. In this review, the key items to design sonosensitive MRI agents will be examined and an overview on the different approaches available so far will be given. Due to the extremely wide range of adopted ultrasound settings and formulations conceived, it is hard to compare the numerous preclinical studies reported. However, in general, a significantly better therapeutic outcome was noticed when exploiting ultrasound triggered drug release in comparison to traditional therapies, thus paving the way to the possible clinical translation of optimized sonosensitive MRI agents.http://journal.frontiersin.org/article/10.3389/fchem.2018.00157/fullsonosensitive agentsimage-guided drug releaseultrasoundsmagnetic resonance imagingtheranosticsthermosensitive liposomes
collection DOAJ
language English
format Article
sources DOAJ
author Francesca Garello
Enzo Terreno
spellingShingle Francesca Garello
Enzo Terreno
Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update
Frontiers in Chemistry
sonosensitive agents
image-guided drug release
ultrasounds
magnetic resonance imaging
theranostics
thermosensitive liposomes
author_facet Francesca Garello
Enzo Terreno
author_sort Francesca Garello
title Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update
title_short Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update
title_full Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update
title_fullStr Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update
title_full_unstemmed Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update
title_sort sonosensitive mri nanosystems as cancer theranostics: a recent update
publisher Frontiers Media S.A.
series Frontiers in Chemistry
issn 2296-2646
publishDate 2018-05-01
description In the tireless search for innovative and more efficient cancer therapies, sonosensitive Magnetic Resonance Imaging (MRI) agents play an important role. Basically, these systems consist of nano/microvesicles composed by a biocompatible membrane, responsive to ultrasound-induced thermal or mechanical effects, and an aqueous core, filled up with a MRI detectable probe and a therapeutic agent. They offer the possibility to trigger and monitor in real time drug release in a spatio-temporal domain, with the expectation to predict the therapeutic outcome. In this review, the key items to design sonosensitive MRI agents will be examined and an overview on the different approaches available so far will be given. Due to the extremely wide range of adopted ultrasound settings and formulations conceived, it is hard to compare the numerous preclinical studies reported. However, in general, a significantly better therapeutic outcome was noticed when exploiting ultrasound triggered drug release in comparison to traditional therapies, thus paving the way to the possible clinical translation of optimized sonosensitive MRI agents.
topic sonosensitive agents
image-guided drug release
ultrasounds
magnetic resonance imaging
theranostics
thermosensitive liposomes
url http://journal.frontiersin.org/article/10.3389/fchem.2018.00157/full
work_keys_str_mv AT francescagarello sonosensitivemrinanosystemsascancertheranosticsarecentupdate
AT enzoterreno sonosensitivemrinanosystemsascancertheranosticsarecentupdate
_version_ 1725886031305113600